// App-Quantinova.ai

: Using Healthcare Claims Data to Analyze the Prevalence of Chronic Myeloid Leukemia in France: A Nationwide Population-Based Study

Researchers

Presenter

  • Stephanie Foulon

Principal Investigators

  • Pascale Cony-Makhoul

  • Agnes Guerci-Bresler

  • Marc Delord

  • Eric Solary

  • Alain Monnereau

  • Julia Bonastre

  • Pascale Tubert Bitter

Medical Centers

  • Biostatistics, Gustave Roussy, Villejuif, France

  • CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud Univ., Villejuif, France

  • B2PHI Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm U1181, UVSQ, Institut Pasteur, Université Paris-Saclay, Villejuif, France

  • Centre Hospitalier Annecy Genevois, Pringy, France

  • Service dHematologie, CHU Brabois, Vandoeuvre-les-Nancy, France

  • Institut Universitaire d'Hématologie, Université Paris 7, Hôpital Saint Louis, Paris, France

  • Department of Surgery, Gustave Roussy Cancer Centre, Villejuif, France

  • Registre des hémopathies malignes de la Gironde, Centre de Lutte Contre le Cancer, F-33076, Bordeaux, Réseau REPIH, Bordeaux, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastrointestinal stromal tumor

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Bosutinib

  • Nilotinib

  • Ponatinib

  • dasatinib

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved